Solid biosciences to present at 39th annual j.p. morgan healthcare conference

Cambridge, mass., jan. 06, 2021 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy (duchenne), today announced that ilan ganot, chief executive officer, president and co-founder, will present at the 39th annual j.p. morgan healthcare conference on thursday, january 14, 2021 at 8:20 am et. following the prepared remarks, several members of the leadership team will be available for q&a.
SLDB Ratings Summary
SLDB Quant Ranking